Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

ILOPROST SALE DI TROMETAMOLO

[1] Iloprost 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 51 💬

2

ILOPROST TROMETAMOL

[2] Iloprost,
Tromethamine (Trometamol)

[2] Tromethamine (Trometamol (JAN/INN)),
Iloprost 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 51 💬

3

Ketorolac Tromethamine
(Trometamol (JAN/INN))

[2] Ketorolac,
Tromethamine (Trometamol)

[2] Tromethamine (Trometamol (JAN/INN)),
Ketorolac 💬

[2] PTGS1,
PTGS2 💬

[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬

[1] 226 💬

4

[1] Tromethamine (Trometamol)

[1] Tromethamine (Trometamol (JAN/INN)) 💬

-

-

[1] 51 💬

5

Tromethamine
(Trometamol (JAN/INN))

[1] Tromethamine (Trometamol)

[1] Tromethamine (Trometamol (JAN/INN)) 💬

-

-

[1] 226 💬